25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

KPX Lifescience.Co.Ltd
Buy, Hold or Sell?

Let's analyze KPX Lifescience.Co.Ltd together

I guess you are interested in KPX Lifescience.Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of KPX Lifescience.Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about KPX Lifescience.Co.Ltd

I send you an email if I find something interesting about KPX Lifescience.Co.Ltd.

1. Quick Overview

1.1. Quick analysis of KPX Lifescience.Co.Ltd (30 sec.)










1.2. What can you expect buying and holding a share of KPX Lifescience.Co.Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
13.8%

What is your share worth?

Current worth
₩1,900.47
Expected worth in 1 year
₩1,263.52
How sure are you?
44.8%

+ What do you gain per year?

Total Gains per Share
₩-636.95
Return On Investment
-35.8%

For what price can you sell your share?

Current Price per Share
₩1,781.00
Expected price per share
₩1,613 - ₩2,115
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of KPX Lifescience.Co.Ltd (5 min.)




Live pricePrice per Share (EOD)
₩1,781.00

2.2. Growth of KPX Lifescience.Co.Ltd (5 min.)




Is KPX Lifescience.Co.Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$25.6m$36.8m-$9m-32.6%

How much money is KPX Lifescience.Co.Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m-$885k-$1.2m-58.0%
Net Profit Margin-87.6%-26.2%--

How much money comes from the company's main activities?

2.3. Financial Health of KPX Lifescience.Co.Ltd (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of KPX Lifescience.Co.Ltd?

Welcome investor! KPX Lifescience.Co.Ltd's management wants to use your money to grow the business. In return you get a share of KPX Lifescience.Co.Ltd.

First you should know what it really means to hold a share of KPX Lifescience.Co.Ltd. And how you can make/lose money.

Speculation

The Price per Share of KPX Lifescience.Co.Ltd is ₩1,781. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of KPX Lifescience.Co.Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in KPX Lifescience.Co.Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩1,900.47. Based on the TTM, the Book Value Change Per Share is ₩-159.24 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-297.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of KPX Lifescience.Co.Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.050.0%-0.110.0%-0.050.0%-0.040.0%-0.030.0%
Usd Book Value Change Per Share0.020.0%-0.110.0%-0.210.0%-0.070.0%0.050.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.0%
Usd Total Gains Per Share0.020.0%-0.110.0%-0.210.0%-0.070.0%0.060.0%
Usd Price Per Share1.37-1.52-3.09-4.01-3.87-
Price to Earnings Ratio7.02--1.34--23.68-8.41-17.01-
Price-to-Total Gains Ratio55.90-1.77--68.83--147.55--60.51-
Price to Book Ratio1.03-1.10-1.58-1.67-1.54-
Price-to-Total Gains Ratio55.90-1.77--68.83--147.55--60.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.2467
Number of shares802
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.11-0.07
Usd Total Gains Per Share-0.11-0.07
Gains per Quarter (802 shares)-89.40-58.75
Gains per Year (802 shares)-357.58-234.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-358-3680-235-245
20-715-7260-470-480
30-1073-10840-705-715
40-1430-14420-940-950
50-1788-18000-1175-1185
60-2145-21580-1410-1420
70-2503-25160-1645-1655
80-2861-28740-1880-1890
90-3218-32320-2115-2125
100-3576-35900-2350-2360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%12.017.00.041.4%12.017.00.041.4%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%10.019.00.034.5%10.019.00.034.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%4.00.025.013.8%4.00.025.013.8%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%13.016.00.044.8%13.016.00.044.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of KPX Lifescience.Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--35.062-159.237+554%-297.222+948%-104.646+398%65.533-46%
Book Value Per Share--1900.4692023.115-6%2861.400-34%3324.779-43%3557.241-47%
Current Ratio--3.1633.049+4%2.700+17%2.611+21%2.943+7%
Debt To Asset Ratio--0.1670.166+1%0.162+3%0.169-1%0.162+3%
Debt To Equity Ratio--0.2010.199+1%0.194+3%0.205-2%0.195+3%
Dividend Per Share----0%-0%-0%16.138-100%
Eps--69.751-150.902+316%-64.694+193%-57.105+182%-39.669+157%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap26715000000.000-42%37852441200.00042643222282.500-11%83168580937.500-54%91410083694.000-59%86650934271.724-56%
Net Profit Margin--0.195-0.876+549%-0.262+234%-0.264+235%-0.189+197%
Operating Margin----0%-0.0390%-0.0650%-0.0560%
Operating Ratio--1.6152.047-21%2.063-22%1.534+5%1.681-4%
Pb Ratio0.937-10%1.0311.097-6%1.585-35%1.668-38%1.536-33%
Pe Ratio6.383-10%7.025-1.340+119%-23.676+437%8.406-16%17.015-59%
Price Per Share1781.000-10%1960.0002176.250-10%4417.500-56%5735.250-66%5529.310-65%
Price To Free Cash Flow Ratio----8.2220%-50.7260%-14.8000%-9.7810%
Price To Total Gains Ratio50.796-10%55.9011.768+3062%-68.832+223%-147.546+364%-60.514+208%
Quick Ratio---1.134-100%3.323-100%2.542-100%2.433-100%
Return On Assets--0.031-0.068+322%-0.020+166%-0.021+167%-0.014+147%
Return On Equity--0.037-0.083+326%-0.024+166%-0.025+168%-0.017+147%
Total Gains Per Share--35.062-159.237+554%-297.222+948%-104.646+398%81.671-57%
Usd Book Value--25691922.90027782599.598-8%36832958.447-30%37575889.189-32%39189463.545-34%
Usd Book Value Change Per Share--0.025-0.111+554%-0.208+948%-0.073+398%0.046-46%
Usd Book Value Per Share--1.3301.416-6%2.003-34%2.327-43%2.490-47%
Usd Dividend Per Share----0%-0%-0%0.011-100%
Usd Eps--0.049-0.106+316%-0.045+193%-0.040+182%-0.028+157%
Usd Free Cash Flow----38002.1510%-770489.5610%-548000.0510%-443773.7780%
Usd Market Cap18700500.000-42%26496708.84029850255.598-11%58218006.656-54%63987058.586-59%60655653.990-56%
Usd Price Per Share1.247-10%1.3721.523-10%3.092-56%4.015-66%3.871-65%
Usd Profit--942950.400-2106930.761+323%-885071.467+194%-745255.952+179%-516970.797+155%
Usd Revenue--4840090.5004305643.745+12%3904907.158+24%4891364.464-1%5400932.126-10%
Usd Total Gains Per Share--0.025-0.111+554%-0.208+948%-0.073+398%0.057-57%
 EOD+3 -4MRQTTM+16 -10YOY+16 -105Y+17 -910Y+12 -16

3.3 Fundamental Score

Let's check the fundamental score of KPX Lifescience.Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.383
Price to Book Ratio (EOD)Between0-10.937
Net Profit Margin (MRQ)Greater than00.195
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than13.163
Debt to Asset Ratio (MRQ)Less than10.167
Debt to Equity Ratio (MRQ)Less than10.201
Return on Equity (MRQ)Greater than0.150.037
Return on Assets (MRQ)Greater than0.050.031
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of KPX Lifescience.Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.904
Ma 20Greater thanMa 501,910.250
Ma 50Greater thanMa 1002,072.560
Ma 100Greater thanMa 2002,197.170
OpenGreater thanClose1,751.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About KPX Lifescience.Co.Ltd

KPX Lifescience.Co.,Ltd. engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. The company offers raw materials for pharmaceuticals, pesticides, and primary intermediates to the pharmaceutical and agrochemical markets. It also develops EDP-CL, an intermediate for piperacillin-based antibiotics, including N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw material; and AM19, an antibiotic intermediate. The company was formerly known as MNH Laboratories Co., Ltd. and changed its name to KPX Lifescience.Co.,Ltd. in September 2008. The company was founded in 2005 and is headquartered in Yeosu, South Korea. KPX Lifescience.Co.,Ltd. is a subsidiary of KPX Holdings Co., Ltd.

Fundamental data was last updated by Penke on 2024-11-19 01:28:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit KPX Lifescience.Co.Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare KPX Lifescience.Co.Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 19.5% means that ₩0.19 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of KPX Lifescience.Co.Ltd:

  • The MRQ is 19.5%. The company is making a huge profit. +2
  • The TTM is -87.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ19.5%TTM-87.6%+107.0%
TTM-87.6%YOY-26.2%-61.4%
TTM-87.6%5Y-26.4%-61.2%
5Y-26.4%10Y-18.9%-7.4%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ19.5%9.8%+9.7%
TTM-87.6%9.5%-97.1%
YOY-26.2%9.9%-36.1%
5Y-26.4%12.9%-39.3%
10Y-18.9%12.6%-31.5%
4.3.1.2. Return on Assets

Shows how efficient KPX Lifescience.Co.Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare KPX Lifescience.Co.Ltd to the Pharmaceuticals industry mean.
  • 3.1% Return on Assets means that KPX Lifescience.Co.Ltd generated ₩0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of KPX Lifescience.Co.Ltd:

  • The MRQ is 3.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is -6.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ3.1%TTM-6.8%+9.8%
TTM-6.8%YOY-2.0%-4.8%
TTM-6.8%5Y-2.1%-4.7%
5Y-2.1%10Y-1.4%-0.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1%3.6%-0.5%
TTM-6.8%3.5%-10.3%
YOY-2.0%5.3%-7.3%
5Y-2.1%5.9%-8.0%
10Y-1.4%4.9%-6.3%
4.3.1.3. Return on Equity

Shows how efficient KPX Lifescience.Co.Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare KPX Lifescience.Co.Ltd to the Pharmaceuticals industry mean.
  • 3.7% Return on Equity means KPX Lifescience.Co.Ltd generated ₩0.04 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of KPX Lifescience.Co.Ltd:

  • The MRQ is 3.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -8.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ3.7%TTM-8.3%+12.0%
TTM-8.3%YOY-2.4%-5.9%
TTM-8.3%5Y-2.5%-5.8%
5Y-2.5%10Y-1.7%-0.8%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%4.6%-0.9%
TTM-8.3%4.6%-12.9%
YOY-2.4%8.2%-10.6%
5Y-2.5%9.1%-11.6%
10Y-1.7%10.3%-12.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of KPX Lifescience.Co.Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient KPX Lifescience.Co.Ltd is operating .

  • Measures how much profit KPX Lifescience.Co.Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare KPX Lifescience.Co.Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of KPX Lifescience.Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-3.9%+3.9%
TTM-5Y-6.5%+6.5%
5Y-6.5%10Y-5.6%-0.9%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-13.2%
TTM-12.0%-12.0%
YOY-3.9%12.4%-16.3%
5Y-6.5%8.6%-15.1%
10Y-5.6%12.1%-17.7%
4.3.2.2. Operating Ratio

Measures how efficient KPX Lifescience.Co.Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.62 means that the operating costs are ₩1.62 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of KPX Lifescience.Co.Ltd:

  • The MRQ is 1.615. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.047. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.615TTM2.047-0.432
TTM2.047YOY2.063-0.016
TTM2.0475Y1.534+0.513
5Y1.53410Y1.681-0.148
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6151.225+0.390
TTM2.0471.220+0.827
YOY2.0631.311+0.752
5Y1.5341.249+0.285
10Y1.6811.240+0.441
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of KPX Lifescience.Co.Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if KPX Lifescience.Co.Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 3.16 means the company has ₩3.16 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of KPX Lifescience.Co.Ltd:

  • The MRQ is 3.163. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.049. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.163TTM3.049+0.114
TTM3.049YOY2.700+0.349
TTM3.0495Y2.611+0.438
5Y2.61110Y2.943-0.332
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1632.213+0.950
TTM3.0492.234+0.815
YOY2.7002.028+0.672
5Y2.6112.199+0.412
10Y2.9431.995+0.948
4.4.3.2. Quick Ratio

Measures if KPX Lifescience.Co.Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare KPX Lifescience.Co.Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of KPX Lifescience.Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.134-1.134
TTM1.134YOY3.323-2.190
TTM1.1345Y2.542-1.408
5Y2.54210Y2.433+0.108
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.926-0.926
TTM1.1340.973+0.161
YOY3.3231.515+1.808
5Y2.5421.591+0.951
10Y2.4331.399+1.034
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of KPX Lifescience.Co.Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of KPX Lifescience.Co.Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare KPX Lifescience.Co.Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.17 means that KPX Lifescience.Co.Ltd assets are financed with 16.7% credit (debt) and the remaining percentage (100% - 16.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of KPX Lifescience.Co.Ltd:

  • The MRQ is 0.167. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.166. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.167TTM0.166+0.001
TTM0.166YOY0.162+0.004
TTM0.1665Y0.169-0.003
5Y0.16910Y0.162+0.007
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1670.345-0.178
TTM0.1660.339-0.173
YOY0.1620.333-0.171
5Y0.1690.315-0.146
10Y0.1620.339-0.177
4.5.4.2. Debt to Equity Ratio

Measures if KPX Lifescience.Co.Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare KPX Lifescience.Co.Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 20.1% means that company has ₩0.20 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of KPX Lifescience.Co.Ltd:

  • The MRQ is 0.201. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.199. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.201TTM0.199+0.002
TTM0.199YOY0.194+0.005
TTM0.1995Y0.205-0.006
5Y0.20510Y0.195+0.010
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2010.547-0.346
TTM0.1990.547-0.348
YOY0.1940.499-0.305
5Y0.2050.476-0.271
10Y0.1950.548-0.353
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings KPX Lifescience.Co.Ltd generates.

  • Above 15 is considered overpriced but always compare KPX Lifescience.Co.Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of 7.02 means the investor is paying ₩7.02 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of KPX Lifescience.Co.Ltd:

  • The EOD is 6.383. Based on the earnings, the company is cheap. +2
  • The MRQ is 7.025. Based on the earnings, the company is cheap. +2
  • The TTM is -1.340. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.383MRQ7.025-0.642
MRQ7.025TTM-1.340+8.365
TTM-1.340YOY-23.676+22.336
TTM-1.3405Y8.406-9.746
5Y8.40610Y17.015-8.609
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD6.38327.863-21.480
MRQ7.02529.844-22.819
TTM-1.34027.532-28.872
YOY-23.67623.102-46.778
5Y8.40627.577-19.171
10Y17.01529.248-12.233
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of KPX Lifescience.Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-8.222+8.222
TTM-8.222YOY-50.726+42.504
TTM-8.2225Y-14.800+6.578
5Y-14.80010Y-9.781-5.019
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.531-29.531
TTM-8.22229.447-37.669
YOY-50.72626.360-77.086
5Y-14.80031.734-46.534
10Y-9.78134.357-44.138
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of KPX Lifescience.Co.Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 1.03 means the investor is paying ₩1.03 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of KPX Lifescience.Co.Ltd:

  • The EOD is 0.937. Based on the equity, the company is cheap. +2
  • The MRQ is 1.031. Based on the equity, the company is underpriced. +1
  • The TTM is 1.097. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.937MRQ1.031-0.094
MRQ1.031TTM1.097-0.065
TTM1.097YOY1.585-0.488
TTM1.0975Y1.668-0.571
5Y1.66810Y1.536+0.131
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD0.9374.659-3.722
MRQ1.0313.381-2.350
TTM1.0973.209-2.112
YOY1.5852.597-1.012
5Y1.6683.278-1.610
10Y1.5364.179-2.643
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets44,075,571
Total Liabilities7,372,824
Total Stockholder Equity36,702,747
 As reported
Total Liabilities 7,372,824
Total Stockholder Equity+ 36,702,747
Total Assets = 44,075,571

Assets

Total Assets44,075,571
Total Current Assets21,770,446
Long-term Assets22,305,125
Total Current Assets
Total Current Assets  (as reported)21,770,446
Total Current Assets  (calculated)0
+/- 21,770,446
Long-term Assets
Long-term Assets  (as reported)22,305,125
Long-term Assets  (calculated)0
+/- 22,305,125

Liabilities & Shareholders' Equity

Total Current Liabilities6,883,927
Long-term Liabilities488,897
Total Stockholder Equity36,702,747
Total Current Liabilities
Total Current Liabilities  (as reported)6,883,927
Total Current Liabilities  (calculated)0
+/- 6,883,927
Long-term Liabilities
Long-term Liabilities  (as reported)488,897
Long-term Liabilities  (calculated)0
+/- 488,897
Total Stockholder Equity
Total Stockholder Equity (as reported)36,702,747
Total Stockholder Equity (calculated)0
+/- 36,702,747
Other
Common Stock Shares Outstanding 19,312
Net Working Capital 14,886,519



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
76,133,254
72,577,401
72,964,194
73,242,016
70,597,849
68,985,675
69,372,426
70,969,340
70,010,670
72,197,729
71,894,429
70,882,111
71,393,319
70,309,011
70,846,460
69,927,302
70,829,644
70,091,850
71,977,239
72,921,022
68,552,777
64,974,586
62,431,733
60,261,204
63,528,621
59,177,089
43,828,428
43,069,471
44,075,571
44,075,57143,069,47143,828,42859,177,08963,528,62160,261,20462,431,73364,974,58668,552,77772,921,02271,977,23970,091,85070,829,64469,927,30270,846,46070,309,01171,393,31970,882,11171,894,42972,197,72970,010,67070,969,34069,372,42668,985,67570,597,84973,242,01672,964,19472,577,40176,133,254
   > Total Current Assets 
44,661,489
40,828,149
38,805,973
41,747,684
37,870,625
34,803,572
30,525,388
32,727,767
29,980,774
32,770,498
31,662,115
30,567,698
30,784,941
27,398,978
24,571,814
23,529,325
28,024,565
26,164,902
26,892,375
28,038,469
24,587,914
23,646,143
26,443,406
24,864,939
28,516,573
24,597,825
21,712,228
21,072,615
21,770,446
21,770,44621,072,61521,712,22824,597,82528,516,57324,864,93926,443,40623,646,14324,587,91428,038,46926,892,37526,164,90228,024,56523,529,32524,571,81427,398,97830,784,94130,567,69831,662,11532,770,49829,980,77432,727,76730,525,38834,803,57237,870,62541,747,68438,805,97340,828,14944,661,489
       Cash And Cash Equivalents 
6,041,893
2,577,304
1,921,726
3,210,130
4,258,738
3,185,075
523,859
1,962,288
2,404,921
3,932,208
7,513,820
6,782,408
6,051,904
4,412,320
2,402,288
2,238,082
3,890,362
2,031,498
3,388,195
0
0
0
2,814,200
2,990,154
6,035,350
4,783,968
6,347,661
5,647,007
0
05,647,0076,347,6614,783,9686,035,3502,990,1542,814,2000003,388,1952,031,4983,890,3622,238,0822,402,2884,412,3206,051,9046,782,4087,513,8203,932,2082,404,9211,962,288523,8593,185,0754,258,7383,210,1301,921,7262,577,3046,041,893
       Short-term Investments 
23,607,604
23,618,932
21,746,817
14,229,068
12,247,716
13,222,932
12,516,699
11,220,288
14,215,034
13,265,492
9,792,816
0
0
13,272,826
12,430,458
12,302,067
14,173,397
14,137,938
12,515,287
12,343,058
10,542,069
10,780,988
13,834,577
13,934,696
11,950,474
9,896,750
8,105,290
6,630,825
0
06,630,8258,105,2909,896,75011,950,47413,934,69613,834,57710,780,98810,542,06912,343,05812,515,28714,137,93814,173,39712,302,06712,430,45813,272,826009,792,81613,265,49214,215,03411,220,28812,516,69913,222,93212,247,71614,229,06821,746,81723,618,93223,607,604
       Net Receivables 
6,216,529
7,671,906
9,201,439
7,750,186
4,243,383
4,507,609
3,282,728
5,099,182
4,155,951
6,320,334
5,574,073
4,503,403
3,715,560
2,993,851
2,037,068
2,251,403
3,424,661
4,156,509
3,563,646
8,285,012
4,245,431
3,267,351
2,613,884
1,867,488
3,431,469
4,054,843
1,451,114
3,908,302
0
03,908,3021,451,1144,054,8433,431,4691,867,4882,613,8843,267,3514,245,4318,285,0123,563,6464,156,5093,424,6612,251,4032,037,0682,993,8513,715,5604,503,4035,574,0736,320,3344,155,9515,099,1823,282,7284,507,6094,243,3837,750,1869,201,4397,671,9066,216,529
       Inventory 
7,600,757
5,806,438
4,846,976
5,708,808
7,067,896
5,154,496
5,530,614
5,584,578
5,402,590
5,304,011
4,892,328
5,609,233
5,786,520
5,712,030
6,648,950
6,024,662
5,666,489
4,901,921
5,731,921
5,261,656
4,498,554
6,035,670
6,014,188
5,448,141
6,333,397
5,259,487
5,310,748
4,504,916
0
04,504,9165,310,7485,259,4876,333,3975,448,1416,014,1886,035,6704,498,5545,261,6565,731,9214,901,9215,666,4896,024,6626,648,9505,712,0305,786,5205,609,2334,892,3285,304,0115,402,5905,584,5785,530,6145,154,4967,067,8965,708,8084,846,9765,806,4387,600,757
       Other Current Assets 
328,566
327,864
379,512
466,973
379,859
519,865
546,599
546,749
293,716
548,695
332,508
252,376
262,298
271,687
80,126
251,209
322,542
173,721
657,552
738,416
540,677
479,029
702,220
185,920
198,888
0
0
-1
0
0-100198,888185,920702,220479,029540,677738,416657,552173,721322,542251,20980,126271,687262,298252,376332,508548,695293,716546,749546,599519,865379,859466,973379,512327,864328,566
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,988,327
35,396,265
35,012,048
34,579,263
22,116,200
21,996,857
22,305,125
22,305,12521,996,85722,116,20034,579,26335,012,04835,396,26535,988,3270000000000000000000000
       Property Plant Equipment 
29,435,280
29,841,826
30,262,754
30,677,497
31,841,818
33,397,590
34,417,731
33,871,582
33,934,493
34,475,774
35,078,885
35,024,064
35,468,729
35,377,286
35,625,630
35,710,779
35,539,795
35,583,957
36,845,612
36,780,975
36,689,742
36,380,071
27,112,458
26,537,715
26,146,053
25,683,109
13,255,677
13,076,414
0
013,076,41413,255,67725,683,10926,146,05326,537,71527,112,45836,380,07136,689,74236,780,97536,845,61235,583,95735,539,79535,710,77935,625,63035,377,28635,468,72935,024,06435,078,88534,475,77433,934,49333,871,58234,417,73133,397,59031,841,81830,677,49730,262,75429,841,82629,435,280
       Long Term Investments 
1,039,481
980,374
3,007,077
0
0
0
2,999,552
3,013,117
5,031,918
3,939,980
3,915,850
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000003,915,8503,939,9805,031,9183,013,1172,999,5520003,007,077980,3741,039,481
       Intangible Assets 
528,873
494,786
491,990
456,300
536,029
472,267
458,695
421,680
384,665
590,392
660,969
607,112
515,527
442,806
370,258
310,168
249,558
210,507
181,716
153,397
125,078
106,109
87,924
70,605
59,256
89,416
27,718
52,987
0
052,98727,71889,41659,25670,60587,924106,109125,078153,397181,716210,507249,558310,168370,258442,806515,527607,112660,969590,392384,665421,680458,695472,267536,029456,300491,990494,786528,873
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000
> Total Liabilities 
12,346,649
9,665,172
10,872,121
12,201,973
9,821,050
8,082,645
10,261,089
11,525,546
10,109,924
11,954,911
11,536,890
11,238,103
10,990,595
9,937,840
11,475,316
11,030,347
12,196,109
12,235,385
15,678,907
16,525,260
12,658,156
9,661,845
9,792,758
8,487,105
12,780,386
9,101,738
7,874,427
7,043,858
7,372,824
7,372,8247,043,8587,874,4279,101,73812,780,3868,487,1059,792,7589,661,84512,658,15616,525,26015,678,90712,235,38512,196,10911,030,34711,475,3169,937,84010,990,59511,238,10311,536,89011,954,91110,109,92411,525,54610,261,0898,082,6459,821,05012,201,97310,872,1219,665,17212,346,649
   > Total Current Liabilities 
11,974,443
9,240,858
10,625,496
11,797,441
9,493,336
7,658,277
9,832,615
10,888,280
9,552,812
11,319,799
11,071,926
10,718,215
10,421,004
9,288,525
10,781,076
10,242,959
11,832,174
11,849,029
15,241,566
15,959,175
12,083,732
9,025,311
9,436,510
8,147,669
12,269,524
8,535,086
7,393,533
6,557,999
6,883,927
6,883,9276,557,9997,393,5338,535,08612,269,5248,147,6699,436,5109,025,31112,083,73215,959,17515,241,56611,849,02911,832,17410,242,95910,781,0769,288,52510,421,00410,718,21511,071,92611,319,7999,552,81210,888,2809,832,6157,658,2779,493,33611,797,44110,625,4969,240,85811,974,443
       Short-term Debt 
4,000,000
3,800,000
4,146,357
5,103,900
4,158,522
0
0
0
0
5,100,000
5,100,000
6,602,358
5,100,000
6,923,512
6,210,957
7,445,520
8,568,012
8,670,497
7,432,508
9,585,020
7,673,060
6,796,166
6,488,327
6,217,361
8,300,000
0
0
0
0
00008,300,0006,217,3616,488,3276,796,1667,673,0609,585,0207,432,5088,670,4978,568,0127,445,5206,210,9576,923,5125,100,0006,602,3585,100,0005,100,00000004,158,5225,103,9004,146,3573,800,0004,000,000
       Short Long Term Debt 
4,000,000
3,800,000
4,146,357
5,103,900
4,158,522
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,488,327
6,217,361
8,300,000
5,644,000
4,800,000
4,800,000
0
04,800,0004,800,0005,644,0008,300,0006,217,3616,488,327000000000000000004,158,5225,103,9004,146,3573,800,0004,000,000
       Accounts payable 
2,322,916
2,582,063
3,133,434
2,255,319
2,312,995
1,125,657
1,320,481
1,920,152
2,079,479
2,558,692
2,538,087
2,195,523
3,231,435
1,278,834
2,835,296
1,501,859
1,486,777
1,242,825
4,114,237
4,392,680
2,319,939
858,064
824,235
744,136
1,944,149
1,460,148
0
571,251
0
0571,25101,460,1481,944,149744,136824,235858,0642,319,9394,392,6804,114,2371,242,8251,486,7771,501,8592,835,2961,278,8343,231,4352,195,5232,538,0872,558,6922,079,4791,920,1521,320,4811,125,6572,312,9952,255,3193,133,4342,582,0632,322,916
       Other Current Liabilities 
5,476,062
2,661,311
3,171,324
4,261,234
2,860,386
2,316,475
3,131,189
2,291,052
1,795,631
3,440,893
3,092,745
1,623,328
1,847,434
882,620
1,428,571
976,124
1,458,065
1,544,184
3,587,841
1,864,727
1,932,923
1,097,762
122,000
152,000
-1
153,999
1
0
0
001153,999-1152,000122,0001,097,7621,932,9231,864,7273,587,8411,544,1841,458,065976,1241,428,571882,6201,847,4341,623,3283,092,7453,440,8931,795,6312,291,0523,131,1892,316,4752,860,3864,261,2343,171,3242,661,3115,476,062
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
356,248
339,436
510,862
566,652
480,895
485,859
488,897
488,897485,859480,895566,652510,862339,436356,2480000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
50,363
47,235
31,420
28,269
25,019
21,837
57,761
51,234
44,447
37,863
18,274
13,255
9,318
0
0
0
0
00009,31813,25518,27437,86344,44751,23457,76121,83725,01928,26931,42047,23550,363000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
136,121
88,425
101,701
140,054
132,858
81,149
0
081,149132,858140,054101,70188,425136,1210000000000000000000000
       Other Liabilities 
372,206
424,314
246,625
404,532
327,714
424,368
428,474
622,755
557,112
635,112
464,964
519,887
519,229
602,079
662,820
759,120
338,915
364,520
379,581
514,851
529,977
598,671
0
0
0
0
0
0
0
0000000598,671529,977514,851379,581364,520338,915759,120662,820602,079519,229519,887464,964635,112557,112622,755428,474424,368327,714404,532246,625424,314372,206
> Total Stockholder Equity
63,786,605
62,912,229
62,092,074
61,040,043
60,776,799
60,903,031
59,111,336
59,443,794
59,900,746
60,242,818
60,357,539
59,644,008
60,402,723
60,371,171
59,371,144
58,896,955
58,633,535
57,856,464
56,298,332
56,395,762
55,894,621
55,312,741
52,638,975
51,774,099
50,748,235
50,075,351
35,954,001
36,025,614
36,702,747
36,702,74736,025,61435,954,00150,075,35150,748,23551,774,09952,638,97555,312,74155,894,62156,395,76256,298,33257,856,46458,633,53558,896,95559,371,14460,371,17160,402,72359,644,00860,357,53960,242,81859,900,74659,443,79459,111,33660,903,03160,776,79961,040,04362,092,07462,912,22963,786,605
   Common Stock
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
7,500,000
0
0
0
0
00007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,0007,500,000
   Retained Earnings 
16,903,122
16,059,495
15,119,802
14,584,383
14,321,139
14,447,371
12,621,520
12,963,899
13,436,994
13,777,043
13,892,113
13,178,807
13,940,086
13,843,739
12,819,512
12,311,803
11,999,338
11,215,634
9,680,279
9,784,472
9,299,523
8,945,570
6,232,015
5,348,879
4,319,275
3,846,262
-10,104,523
12,530,057
0
012,530,057-10,104,5233,846,2624,319,2755,348,8796,232,0158,945,5709,299,5239,784,4729,680,27911,215,63411,999,33812,311,80312,819,51213,843,73913,940,08613,178,80713,892,11313,777,04313,436,99412,963,89912,621,52014,447,37114,321,13914,584,38315,119,80216,059,49516,903,122
   Capital Surplus 
0
0
0
0
0
0
0
0
0
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
38,955,660
0
0
0
0
000038,955,66038,955,66038,955,66038,955,66038,955,66038,955,66038,955,66038,955,66038,955,66038,955,66038,955,66038,955,66038,955,66038,955,66038,955,66038,955,660000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
427,823
397,074
516,612
0
0
0
34,156
24,235
8,092
10,115
9,767
9,542
6,978
71,772
95,972
129,492
178,537
185,171
162,393
155,631
139,438
-88,489
0
0
0
0
0
0
0
0000000-88,489139,438155,631162,393185,171178,537129,49295,97271,7726,9789,5429,76710,1158,09224,23534,156000516,612397,074427,823



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue22,369,480
Cost of Revenue-24,679,918
Gross Profit-2,310,438-2,310,438
 
Operating Income (+$)
Gross Profit-2,310,438
Operating Expense-27,012,506
Operating Income-4,643,026-29,322,943
 
Operating Expense (+$)
Research Development112,115
Selling General Administrative795,769
Selling And Marketing Expenses0
Operating Expense27,012,506907,883
 
Net Interest Income (+$)
Interest Income697,582
Interest Expense-240,433
Other Finance Cost-9,047
Net Interest Income448,103
 
Pretax Income (+$)
Operating Income-4,643,026
Net Interest Income448,103
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,357,737-4,643,026
EBIT - interestExpense = -240,433
-16,357,737
-16,117,305
Interest Expense240,433
Earnings Before Interest and Taxes (EBIT)0-16,117,305
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-16,357,737
Tax Provision-0
Net Income From Continuing Ops-16,357,737-16,357,737
Net Income-16,357,737
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-448,103
 

Technical Analysis of KPX Lifescience.Co.Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of KPX Lifescience.Co.Ltd. The general trend of KPX Lifescience.Co.Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine KPX Lifescience.Co.Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of KPX Lifescience.Co.Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,980 < 1,980 < 2,115.

The bearish price targets are: 1,681 > 1,613.

Tweet this
KPX Lifescience.Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of KPX Lifescience.Co.Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

KPX Lifescience.Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of KPX Lifescience.Co.Ltd. The current macd is -101.68501945.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the KPX Lifescience.Co.Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for KPX Lifescience.Co.Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the KPX Lifescience.Co.Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
KPX Lifescience.Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartKPX Lifescience.Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of KPX Lifescience.Co.Ltd. The current adx is 25.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell KPX Lifescience.Co.Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
KPX Lifescience.Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of KPX Lifescience.Co.Ltd. The current sar is 1,695.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
KPX Lifescience.Co.Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of KPX Lifescience.Co.Ltd. The current rsi is 35.90. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
KPX Lifescience.Co.Ltd Daily Relative Strength Index (RSI) ChartKPX Lifescience.Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of KPX Lifescience.Co.Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the KPX Lifescience.Co.Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
KPX Lifescience.Co.Ltd Daily Stochastic Oscillator ChartKPX Lifescience.Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of KPX Lifescience.Co.Ltd. The current cci is -76.89150607.

KPX Lifescience.Co.Ltd Daily Commodity Channel Index (CCI) ChartKPX Lifescience.Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of KPX Lifescience.Co.Ltd. The current cmo is -25.4875693.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
KPX Lifescience.Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartKPX Lifescience.Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of KPX Lifescience.Co.Ltd. The current willr is -75.84541063.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that KPX Lifescience.Co.Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
KPX Lifescience.Co.Ltd Daily Williams %R ChartKPX Lifescience.Co.Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of KPX Lifescience.Co.Ltd.

KPX Lifescience.Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of KPX Lifescience.Co.Ltd. The current atr is 99.54.

KPX Lifescience.Co.Ltd Daily Average True Range (ATR) ChartKPX Lifescience.Co.Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of KPX Lifescience.Co.Ltd. The current obv is 134,724,308.

KPX Lifescience.Co.Ltd Daily On-Balance Volume (OBV) ChartKPX Lifescience.Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of KPX Lifescience.Co.Ltd. The current mfi is 27.08.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
KPX Lifescience.Co.Ltd Daily Money Flow Index (MFI) ChartKPX Lifescience.Co.Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for KPX Lifescience.Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-07-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

KPX Lifescience.Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of KPX Lifescience.Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.904
Ma 20Greater thanMa 501,910.250
Ma 50Greater thanMa 1002,072.560
Ma 100Greater thanMa 2002,197.170
OpenGreater thanClose1,751.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of KPX Lifescience.Co.Ltd with someone you think should read this too:
  • Are you bullish or bearish on KPX Lifescience.Co.Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about KPX Lifescience.Co.Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about KPX Lifescience.Co.Ltd

I send you an email if I find something interesting about KPX Lifescience.Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about KPX Lifescience.Co.Ltd.

Receive notifications about KPX Lifescience.Co.Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.